Skip to main content

Advertisement

SpringerLink
Log in

Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The PU.1 transcription factor is a crucial regulator of hematopoiesis, and its expression is altered in various leukemic processes. It has been shown that expression of PU.1 is severely impaired in patients with chronic myeloid leukemia (CML), but the mechanism underlying this effect remains unknown. Through bisulfite sequencing, semi-quantitative PCR, and indirect immunofluorescence and Western blot techniques, we found aberrant methylation in the promoter region of transcription factor PU.1 in CML patients both in the chronic and blast crisis phases, as well as in the CML blast K562 cell line. Of these, several CpG sites were more highly methylated in blast crisis than chronic phase, while no methylation of these sites was observed in healthy individuals. Interestingly, CML patients achieved complete cytogenetic remission under imatinib mesylate treatment, but the aberrant methylation status of PU.1 was not reversed. Down-regulation of PU.1 expression at the mRNA and protein levels was also observed in association with aberrant methylation. Thus, for the first time, we have revealed a potential epigenetic modification of PU.1 in CML, which may be responsible for the down-regulation of PU.1. These data suggest that aberrant methylation of PU.1 may play a role in CML pathogenesis, and may therefore serve as a useful biomarker and potential target for demethylating drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Quintás-Cardama A, Cortes JE. Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc. 2006;81(7):973–88.

    Article  PubMed  Google Scholar 

  2. Ito T, Nishiyama C, Nakano N, et al. Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma. Int Immunol. 2009;21(7):803–16.

    Article  PubMed  CAS  Google Scholar 

  3. Oikawa T, Yamada T, Kihara-Negishi F, et al. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis. Cell Death Differ. 1999;6(7):599–608.

    Article  PubMed  CAS  Google Scholar 

  4. Kosmider O, Denis N, Lacout C, et al. Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice. Cancer Cell. 2005;8(6):467–78.

    Article  PubMed  CAS  Google Scholar 

  5. Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol. 2007;28(3):108–14.

    Article  PubMed  CAS  Google Scholar 

  6. Rosenbauer F, Wagner K, Kutok JL, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 2004;36(6):624–30.

    Article  PubMed  CAS  Google Scholar 

  7. Zhang S-J, Ma L-Y, Huang Q-H, et al. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA. 2008;105(6):2076–81.

    Article  PubMed  CAS  Google Scholar 

  8. Albajar M, Gutierrez P, Richard C, et al. PU.1 expression is restored upon treatment of chronic myeloid leukemia patients. Cancer Lett. 2008;270(2):328–36.

    Article  PubMed  CAS  Google Scholar 

  9. Plass C, Soloway PD. DNA methylation, imprinting and cancer. Eur J Hum Genet. 2002;10(1):6–16.

    Article  PubMed  CAS  Google Scholar 

  10. Kinoshita T. Epigenetic inactivation of tumor suppressor genes in hematologic malignancies. Int J Hematol. 2004;80(2):108–19.

    Article  PubMed  CAS  Google Scholar 

  11. Yang MY, Chang JG, Lin PM, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97(12):1298–307.

    Article  PubMed  CAS  Google Scholar 

  12. Nguyen TT, Mohrbacher AF, Tsai YC, et al. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications. Blood. 2000;95(9):2990–2.

    PubMed  CAS  Google Scholar 

  13. Yang MY, Liu TC, Chang JG, et al. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood. 2003;101(8):3205–11.

    Article  PubMed  CAS  Google Scholar 

  14. Liu TC, Lin SF, Chang JG, et al. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. Br J Haematol. 2003;123(4):654–61.

    Article  PubMed  CAS  Google Scholar 

  15. Tatetsu H, Ueno S, Hata H, et al. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth. Cancer Res. 2007;67(11):5328–36.

    Article  PubMed  CAS  Google Scholar 

  16. Dakic A, Metcalf D, Di Rago L, et al. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201(9):1487–502.

    Article  PubMed  CAS  Google Scholar 

  17. Chou ST, Khandros E, Bailey LC, et al. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood. 2009;114(5):983–94.

    Article  PubMed  CAS  Google Scholar 

  18. DeKoter RP, Schweitzer BL, Kamath MB, et al. Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem. 2007;282(19):14194–204.

    Article  PubMed  CAS  Google Scholar 

  19. Kastner P, Chan S. PU.1: a crucial and versatile player in hematopoiesis and leukemia. Int J Biochem Cell Biol. 2008;40(1):22–7.

    Article  PubMed  CAS  Google Scholar 

  20. Cook WD, McCaw BJ, Herring C, et al. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood. 2004;104(12):3437–44.

    Article  PubMed  CAS  Google Scholar 

  21. Mueller BU, Pabst T, Osato M, et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood. 2002;100(3):998–1007.

    Article  PubMed  CAS  Google Scholar 

  22. Metcalf D, Dakic A, Mifsud S, et al. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci USA. 2006;103(5):1486–91.

    Article  PubMed  CAS  Google Scholar 

  23. Vangala RK, Heiss-Neumann MS, Rangatia JS, et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood. 2003;101(1):270–7.

    Article  PubMed  CAS  Google Scholar 

  24. Wang KK, Shi JT, Wang P, Zhu XH, He MM, Fang H, Du YZ, Zhang J. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Cancer Cell. 2010;17(2):186–97.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank all members of the Department of Hematology, Xin Hua Hospital, Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, for their support. This work was supported in part by the Shanghai Jiao Tong University (SJTU), School of Medicine natural science Grant (09XJ077).

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

  1. Department of Hematology, Xin Hua Hospital, Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, 1665 Kong Jiang Road, Shanghai, 200092, China

    Hui Yang, Hui Liang, Rong Tao, Si-guo Hao & Li-yuan Ma

  2. Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China

    Jing-song Yan

Authors
  1. Hui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing-song Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rong Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Si-guo Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li-yuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Li-yuan Ma.

Additional information

H. Yang and H. Liang contributed equally to this work.

About this article

Cite this article

Yang, H., Liang, H., Yan, Js. et al. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia. Int J Hematol 96, 65–73 (2012). https://doi.org/10.1007/s12185-012-1106-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1106-x

Keywords

Search

Navigation